A Look at Mikhail Blagosklonny’s Research Achievements

Mikhail Blagosklonny, MD, Ph.D. is one of the renowned scientists behind the research scenes in the fight against cancer and the aging process. His research interest areas included “molecular and cellular biology to clinical investigations and specifically include oncogenes and tumor suppressors, signal transduction, cell cycle, mitosis, apoptosis, anticancer therapeutics with emphasis on translation of basic science into new anticancer strategies such as exploiting cancer cell cycling and drug resistance for selective protection of normal cells.” Dr. Blagosklonny is a Professor of Oncology at the Rosewell Park Cancer Institute in Buffalo, NY since 2009. He also served as an Associate Professor of medicine at New York Medical College in Valhalla, NY in 2002 and a Senior Scientist at Ordway Research Institute, Albany, NY. He received both his MD in internal medicine and Ph.D. in experimental medicine from the reputable First Pavlov State Medical University of St. Peterburg in Russia. Read more on Hardware Gurus.

In his role at Rosewell Park Institute, Dr. Blagosklonny is revered for his distinctive concepts he created in cancer therapy and biology. The Impact Journals acknowledged him for his tremendous assistance in facilitating the development of preventive new anti-cancer methods and strategies. As a result of protecting normal body cells from the ill effects of therapeutic treatments, it slows down cancer via the delay in the aging process in organisms. He has also been a proponent fighting cancer through the slowdown of aging and advocated for the use of rapamycin, a standard cancer drug for the possible treatment for a longer life span.

Mikhail Blgosklonny is an Associate Editor of Cancer Biology and Therapy health journal, and doubles as the Founder Editor and Editor in Chief of Cell Cycle, Aging, Oncotarget and Oncoscience Journals. He serves as Editor for Cancer Biology & Therapy, Autophagy, Cancer Research, Cell Death and Differentiation, International Journal of Cancer, The American Journal of Pathology and PLOS ONE respectively. He has published over 300 research articles as well as cancer research reviews and book chapters to his credit. He is the author of “hyperfunction hypothesis of aging including anti-cancer approaches such as cryotherapy and chemotherapeutic engineering.” Read more on templeofthecave.com

Reference:

An Overview of Oncologist Mikhail Blagosklonny’s Life and Career